Acumen Hypotension Prediction Index (HPI) Feature Software vs Rapid RV/LV

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Acumen Hypotension Prediction Index (HPI) Feature Software

by Edwards Lifesciences

Rapid RV/LV

by RapidAI (formerly iSchemaView)

AI Verdict

These two tools are adjacent in their application of AI within cardiology but serve distinct purposes. Acumen HPI focuses on real-time prediction and proactive management of hypotensive events using physiological data, primarily in critical care settings. In contrast, Rapid RV/LV utilizes AI to rapidly assess pulmonary embolism severity by analyzing CTPA imaging, aiding in diagnostic workflows for radiologists and cardiologists.

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…

Choose Acumen Hypotension Prediction Index (HPI) if your clinical focus is on proactive, real-time hemodynamic management to prevent hypotensive events in critically ill or surgical patients. This tool is ideal for anesthesiologists and critical care teams seeking early warnings and actionable insights into a patient's hemodynamic status to intervene before blood pressure drops, thereby reducing the incidence and severity of hypotension.

View Acumen Hypotension Prediction Index (HPI) Feature Software →

Choose Rapid RV/LV if…

Choose Rapid RV/LV if your priority is the rapid and accurate assessment of pulmonary embolism severity through automated analysis of CTPA scans. This tool is best suited for radiologists, cardiologists, and pulmonologists who require consistent, AI-powered measurements of right and left ventricle ratios to quickly stratify PE risk and guide urgent treatment decisions in acute care settings.

View Rapid RV/LV →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Acumen Hypotension Prediction Index (HPI) Feature Software	Rapid RV/LV
Pricing	Contact vendor	Contact vendor for pricing information.
Deployment	Integrated into Edwards Lifesciences HemoSphere advanced monitoring platform.	On-premises (dedicated server or virtual machine) or hybrid (on-premises/cloud with secure link to cloud), connecting to hospital LAN/firewall.
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Acumen Hypotension Prediction Index (HPI) Feature Software

Tool A, Acumen HPI, is integrated into the Edwards Lifesciences HemoSphere platform, offering 'Smart Alerts and Smart Trend screen' and a 'Relationship View screen' for intuitive, real-time hemodynamic insights. This provides clinicians with interactive and interpretative data at the bedside for proactive decision-making.

Clinical Value

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI has 'demonstrated reduction in incidence, duration, and severity of intraoperative hypotension,' directly linking it to improved patient outcomes by preventing adverse events. While Tool B offers rapid assessment and reduces inter-rater variability, Tool A's explicit claim of reducing adverse event severity is a stronger indicator of direct clinical impact.

Pricing & Value

Tie

Both tools require direct contact with the vendor for pricing information, making it impossible to compare their cost or assess their relative value proposition. Neither provides publicly available pricing details or transparent cost-benefit analyses.

Enterprise Readiness

Tie

Both tools are FDA-cleared, HIPAA compliant, and offer Business Associate Agreements (BAAs), indicating strong regulatory and security readiness. Tool A integrates into an existing monitoring platform, while Tool B offers flexible on-premises or hybrid deployment options, making both suitable for enterprise environments.

Innovation

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI is described as a 'first-of-its-kind technology' that uses machine learning to 'predicts hypotension up to 15 minutes before an event.' This predictive, real-time physiological monitoring represents a more novel and proactive application of AI compared to automated image analysis, which is a more established AI application in healthcare.

Support & Docs

Tie

The provided structured facts do not contain specific details regarding the level of support or documentation for either tool. While both companies are reputable and likely offer comprehensive support, there is insufficient information to distinguish between them.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Acumen Hypotension Prediction Index (HPI) Feature Software	Rapid RV/LV
Tool Name	Acumen Hypotension Prediction Index (HPI) Feature Software	Rapid RV/LV
Company	Edwards Lifesciences	RapidAI (formerly iSchemaView)
Primary Function	Predictive monitoring tool that uses machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs.	AI tool for rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans.
Tagline	A first-of-its-kind technology that detects and helps clinicians treat hemodynamic instability.	AI-powered rapid assessment of pulmonary embolism severity.
Key Output/Metric	Hypotension Prediction Index (HPI) parameter (0-100 score)	Calculation of RV/LV ratio
Target Medical Condition	Hypotension	Pulmonary embolism severity

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index (HPI) Feature Software and Rapid RV/LV.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does Acumen HPI integrate into existing perioperative and critical care workflows, and what is its demonstrated clinical impact on hypotensive events?

Acumen HPI integrates into the Edwards Lifesciences HemoSphere advanced monitoring platform, providing a predictive index (0-100 score) and Smart Alerts for impending hypotensive events up to 15 minutes in advance. Clinical studies have demonstrated that Acumen HPI software, when combined with a treatment protocol, significantly reduces the incidence, duration, and severity of intraoperative hypotension.

How does Rapid RV/LV integrate into the diagnostic imaging workflow for pulmonary embolism, and what is its primary clinical benefit in assessing PE severity?

Rapid RV/LV by RapidAI is designed to analyze CTPA images and automatically calculate the RV/LV ratio within minutes of a scan, connecting to the hospital LAN/firewall. This rapid, AI-powered assessment aids in quickly determining pulmonary embolism severity and reduces inter-rater variability in interpretations.

Which clinical specialties are the primary beneficiaries of each tool, and what specific clinical problems do they address?

Acumen HPI is primarily for Anesthesiology, Critical Care, and Emergency Medicine, focusing on proactive hemodynamic management to prevent and treat hypotension. Rapid RV/LV supports Cardiology, Pulmonology, and Radiology by providing rapid, automated assessment of pulmonary embolism severity from CTPA scans.

What is the expected learning curve for physicians to effectively utilize and interpret the outputs of each tool in their clinical decision-making?

For Acumen HPI, clinicians will learn to interpret the HPI parameter (0-100 score), Smart Alerts, and the Relationship View, which provides insights into preload, afterload, and contractility. Rapid RV/LV automates the calculation of the familiar RV/LV ratio from CTPA images, providing annotated images that may have a relatively straightforward interpretation for specialists.

What evidence supports the accuracy and reliability of each tool's core functionality?

Acumen HPI uses machine learning algorithms to predict hypotension up to 15 minutes before an event, demonstrating high accuracy with a specificity of 89% and sensitivity of 90% at 10 minutes prior to an event. Rapid RV/LV provides AI-powered automated measurements of ventricular diameters from CTPA images, which helps reduce inter-rater variability in assessing PE severity.

How do these tools contribute to time-to-value in patient care?

Acumen HPI provides predictive insights up to 15 minutes before a hypotensive event, enabling proactive interventions and potentially reducing the duration and severity of hypotension. Rapid RV/LV delivers automated RV/LV ratio calculations within minutes of a CTPA scan, facilitating quicker risk stratification and aiding in timely treatment decisions for pulmonary embolism.